News
WXIBF
2.740
NaN%
--
Artisan Sustainable Emerging Markets Fund Q1 2025 Commentary
Seeking Alpha · 3d ago
Weekly Report: what happened at WXIBF last week (0414-0418)?
Weekly Report · 6d ago
Weekly Report: what happened at WXIBF last week (0407-0411)?
Weekly Report · 04/14 09:46
Weekly Report: what happened at WXIBF last week (0331-0404)?
Weekly Report · 04/07 09:46
WuXi Biologics Announces Hong Kong Address Change and Completes Vaccine Facility Transaction
TipRanks · 04/01 11:39
Wuxi Biologics (Cayman) (WXIBF) Receives a Buy from Jefferies
TipRanks · 03/31 12:17
Weekly Report: what happened at WXIBF last week (0324-0328)?
Weekly Report · 03/31 09:50
WuXi Biologics: Strong Growth and Strategic Expansion Drive Buy Rating and Target Price Increase
TipRanks · 03/27 11:56
Wuxi Biologics Grants Over 25 Million Restricted Shares to Employees
TipRanks · 03/26 13:18
Wuxi Biologics Reports Strong 2024 Earnings Growth
TipRanks · 03/26 03:55
Wuxi Biologics Reports Robust 2024 Financial Performance Amid Project Expansion
TipRanks · 03/25 22:29
WuXi Biologics to Present 2024 Annual Results via Conference Calls
TipRanks · 03/25 22:11
Weekly Report: what happened at WXIBF last week (0317-0321)?
Weekly Report · 03/24 09:46
Weekly Report: what happened at WXIBF last week (0310-0314)?
Weekly Report · 03/17 09:49
Weekly Report: what happened at WXIBF last week (0303-0307)?
Weekly Report · 03/10 09:50
Weekly Report: what happened at WXIBF last week (0224-0228)?
Weekly Report · 03/03 09:50
Hold Rating for WuXi Biologics Amid Biosecure Act Risks and Regulatory Challenges
TipRanks · 02/24 13:29
Weekly Report: what happened at WXIBF last week (0217-0221)?
Weekly Report · 02/24 09:50
WuXi Biologics Schedules Board Meeting for Annual Results Approval
TipRanks · 02/24 00:10
Weekly Report: what happened at WXIBF last week (0210-0214)?
Weekly Report · 02/17 09:49
More
Webull provides a variety of real-time WXIBF stock news. You can receive the latest news about Wuxi Bio through multiple platforms. This information may help you make smarter investment decisions.
About WXIBF
WuXi Biologics (Cayman) Inc is an investment holding company principally engaged in the provision of end-to-end solutions and services for biologics discovery, development and manufacturing to customers involving in biologics industry. The Company mainly operates its business through two segments. The Biologics segment mainly engages in the provision of biologics discovery, development and manufacturing. The WuXi XDC (XDC) segment mainly engages in the provision of contract research, development and manufacturing organization (CRDMO) services for antibody-drug conjugate (ADCs) and various bioconjugates. The Company mainly conducts its business in the domestic and overseas markets.